table of content
1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines for Infectious Diseases Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines for Infectious Diseases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines for Infectious Diseases Overall Market Size
2.1 Global mRNA Vaccines for Infectious Diseases Market Size: 2022 VS 2032
2.2 Global mRNA Vaccines for Infectious Diseases Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Vaccines for Infectious Diseases Players in Global Market
3.2 Top Global mRNA Vaccines for Infectious Diseases Companies Ranked by Revenue
3.3 Global mRNA Vaccines for Infectious Diseases Revenue by Companies
3.4 Top 3 and Top 5 mRNA Vaccines for Infectious Diseases Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Vaccines for Infectious Diseases Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Vaccines for Infectious Diseases Players in Global Market
3.6.1 List of Global Tier 1 mRNA Vaccines for Infectious Diseases Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Vaccines for Infectious Diseases Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccines for Infectious Diseases Market Size Markets, 2022 & 2032
4.1.2 Infectious Disease Vaccines
4.1.3 Cancer Vaccines
4.2 By Type - Global mRNA Vaccines for Infectious Diseases Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccines for Infectious Diseases Revenue, 2018-2023
4.2.2 By Type - Global mRNA Vaccines for Infectious Diseases Revenue, 2024-2032
4.2.3 By Type - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccines for Infectious Diseases Market Size, 2022 & 2032
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application - Global mRNA Vaccines for Infectious Diseases Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccines for Infectious Diseases Revenue, 2018-2023
5.2.2 By Application - Global mRNA Vaccines for Infectious Diseases Revenue, 2024-2032
5.2.3 By Application - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global mRNA Vaccines for Infectious Diseases Market Size, 2022 & 2032
6.2 By Region - Global mRNA Vaccines for Infectious Diseases Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccines for Infectious Diseases Revenue, 2018-2023
6.2.2 By Region - Global mRNA Vaccines for Infectious Diseases Revenue, 2024-2032
6.2.3 By Region - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.3.2 US mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.3.3 Canada mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.3.4 Mexico mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.4.2 Germany mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.3 France mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.4 U.K. mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.5 Italy mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.6 Russia mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.7 Nordic Countries mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.8 Benelux mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.5.2 China mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.3 Japan mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.4 South Korea mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.5 Southeast Asia mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.6 India mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.6.2 Brazil mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.6.3 Argentina mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.7.2 Turkey mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7.3 Israel mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7.4 Saudi Arabia mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7.5 UAE mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
7 mRNA Vaccines for Infectious Diseases Companies Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.1.5 Moderna Therapeutics Key News & Latest Developments
7.2 CureVac
7.2.1 CureVac Company Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines for Infectious Diseases Major Product Offerings
7.2.4 CureVac mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.2.5 CureVac Key News & Latest Developments
7.3 Translate Bio
7.3.1 Translate Bio Company Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Major Product Offerings
7.3.4 Translate Bio mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.3.5 Translate Bio Key News & Latest Developments
7.4 BioNTech
7.4.1 BioNTech Company Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines for Infectious Diseases Major Product Offerings
7.4.4 BioNTech mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.4.5 BioNTech Key News & Latest Developments
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.5.5 Sangamo Therapeutics Key News & Latest Developments
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Major Product Offerings
7.6.4 Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.6.5 Argos Therapeutics Key News & Latest Developments
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Major Product Offerings
7.7.4 In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.7.5 In-Cell-Art Key News & Latest Developments
7.8 eTheRNA
7.8.1 eTheRNA Company Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Major Product Offerings
7.8.4 eTheRNA mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.8.5 eTheRNA Key News & Latest Developments
7.9 Ethris
7.9.1 Ethris Company Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines for Infectious Diseases Major Product Offerings
7.9.4 Ethris mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.9.5 Ethris Key News & Latest Developments
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.10.5 Tiba Biotechnology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
